Akèy › Sindrom Bronchiolit Obliteran › Washington › Seattle
Etid klinik pou Sindrom Bronchiolit Obliteran nan Seattle, WA
11 etid pou Sindrom Bronchiolit Obliteran ap chèche patisipan nan sit nan ak bò kote Seattle (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
Ap rekriteFaz 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
Ap rekriteFaz 2
- Fred Hutchinson Cancer Research Center- Site Number : 8400002, Seattle
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
Ap rekriteFaz 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
Ap rekriteFaz 2
- Fred Hutchinson Cancer Research Center, Seattle
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Ap rekriteFaz 2
- Seattle Childrens Hospital, Seattle
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Ap rekriteEtid obsèvasyon
- Fred Hutchinson Cancer Research Center, Seattle
Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease
Ap rekrite
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Ap rekriteFaz 2
- Fred Hutchinson Cancer Research Center, Seattle
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Ap rekriteFaz 2
- Fred Hutchinson Cancer Center, Seattle
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Ap rekriteFaz 3
- Fred Hutchinson Cancer Research Center, Seattle
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Ap rekriteFaz 1
- Fred Hutchinson Cancer Center, Seattle
Etid Sindrom Bronchiolit Obliteran nan lòt vil
- Boston, MA13 etid
- Atlanta, GA10 etid
- New York City, NY9 etid
- Houston, TX8 etid
- Los Angeles, CA7 etid
- Miami, FL7 etid
- Baldwin Park, CA6 etid
- Tampa, FL6 etid
- Durham, NC6 etid
- Philadelphia, PA6 etid
- Washington, DC6 etid
- Chicago, IL5 etid
Lòt etid nan Seattle
- Kansè Poumon ki pa ti selil53 etid
- Kansè (tout kalite)49 etid
- Kansè pwostat42 etid
- Leksemi mieloïd egi40 etid
- Kansè nan tete39 etid
- Kansè Metastatik39 etid
- Kansè kolorektal34 etid
- Kansè poumon33 etid
- Kansè ovè30 etid
- Myelom Miltip22 etid
- Sendwòm myelodisplastik21 etid
- Leksemi limfoblastik egi21 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.